Handelsbanken Fonder’s Ironwood Pharmaceuticals IRWD Stock Holding History

Handelsbanken Fonder’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-59,455	Closed	-$245K	–	1561
2024 Q3	$245K	Buy	59,455 +11,600	+24%	+$62.4K	﹤0.01%	1464
2024 Q2	$312K	Hold	47,855	–	–	﹤0.01%	1369
2024 Q1	$417K	Hold	47,855	–	–	﹤0.01%	1243
2023 Q4	$547K	Buy	47,855 +18,900	+65%	+$187K	﹤0.01%	1108
2023 Q3	$279K	Hold	28,955	–	–	﹤0.01%	1345
2023 Q2	$308K	Hold	28,955	–	–	﹤0.01%	1331
2023 Q1	$305K	Hold	28,955	–	–	﹤0.01%	1281
2022 Q4	$359K	Hold	28,955	–	–	﹤0.01%	1147
2022 Q3	$300K	Hold	28,955	–	–	﹤0.01%	1253
2022 Q2	$334K	Hold	28,955	–	–	﹤0.01%	1269
2022 Q1	$364K	Hold	28,955	–	–	﹤0.01%	1408
2021 Q4	$338K	Hold	28,955	–	–	﹤0.01%	1570
2021 Q3	$378K	Hold	28,955	–	–	﹤0.01%	1506
2021 Q2	$373K	Buy	28,955 +1,900	+7%	+$21.7K	﹤0.01%	1560
2021 Q1	$302K	Hold	27,055	–	–	﹤0.01%	1446
2020 Q4	$308K	Hold	27,055	–	–	﹤0.01%	1400
2020 Q3	$243K	Hold	27,055	–	–	﹤0.01%	1331
2020 Q2	$279K	Buy	+27,055	New	+$277K	﹤0.01%	1258

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Handelsbanken Fonder's IRWD Position: Q4 2024 in Review

Handelsbanken Fonder sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 59,455 shares — an estimated $245K sold.

Handelsbanken Fonder first reported a position in IRWD in Q2 2020 and held it in 18 quarters. The position peaked at $547K in Q4 2023. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.

Handelsbanken Fonder reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Handelsbanken Fonder sold 59,455 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $245K.
Handelsbanken Fonder first reported a position in Ironwood Pharmaceuticals in Q2 2020 and held it in 18 quarters.
Handelsbanken Fonder's Ironwood Pharmaceuticals position peaked at $547K in Q4 2023.
223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.

Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.